Still, more data is needed, and questions remain about cost, long-term safety, and access.
Groups with greater drops of liver triglycerides were women, Hispanic and non-Hispanic whites, and people older than 60 years
Asia Pac J Clin Nutr 25(2):221226
By mimicking the action of natural GLP-1 in the body, these medications help curb hunger signals and reduce food intake, making it easier for individuals to create a calorie deficit and lose weight
Glucose as a modifiable cause of atherosclerotic cardiovascular disease: insights from type 1 diabetes and transplantation
Several phase 3 trials evaluating retatrutide are expected to complete in 2026, and Lilly plans to submit retatrutide by the end of 2026 based on the TRIUMPH trials in obesity, a Lilly spokesperson told Everyday Health